| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Repare Therapeutics Inc. (RPTX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. RPTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 0 | - | - | |
| VP | 0 | - | - | |
| Dir | 0 | - | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2025 | Koehler Maria82 | EVP, Chief Medical Officer | Sell | 3,596 | $1.14 | $4,099.44 | -1.6% | +31.0% | - | |
| Mar 12, 2025 | Segal Lloyd Mitchell85 | President And CEO | Sell | 21,179 | $1.14 | $24,144.06 | -14.5% | +31.0% | - | |
| Mar 12, 2025 | Zinda Michael85 | EVP, Chief Scientific Officer | Sell | 5,611 | $1.14 | $6,396.54 | -6.5% | +31.0% | - | |
| Mar 12, 2025 | Forte Steve82 | EVP, Chief Financial Officer | Sell | 6,884 | $1.14 | $7,847.76 | -11.2% | +31.0% | - | |
| Apr 1, 2024 | Segal Lloyd Mitchell85 | President And CEO | Sell | 5,141 | $4.62 | $23,776.33 | -2.3% | -29.1% | -78.3% | |
| Apr 1, 2024 | Forte Steve82 | EVP, Chief Financial Officer | Sell | 1,614 | $4.62 | $7,448.79 | -1.8% | -29.1% | -78.3% | |
| Apr 1, 2024 | Zinda Michael85 | EVP, Chief Scientific Officer | Sell | 860 | $4.65 | $3,998.60 | -0.6% | -29.1% | -78.3% | |
| Apr 1, 2024 | Koehler Maria82 | EVP, Chief Medical Officer | Sell | 800 | $4.65 | $3,718.00 | -0.2% | -29.1% | -78.3% | |
| Mar 27, 2024 | Forte Steve82 | EVP, Chief Financial Officer | Sell | 2,475 | $4.67 | $11,558.25 | -1.9% | -27.0% | -77.1% | |
| Mar 27, 2024 | Zinda Michael85 | EVP, Chief Scientific Officer | Sell | 1,350 | $4.67 | $6,304.50 | -0.6% | -27.0% | -77.1% |